14-01-2019

NEW: RC-PCR for NGS library generation

NimaGen B.V. today announce the agreement of licensing terms for a novel One Step PCR technology employing reverse complement probes from the Salisbury NHS Foundation Trust, of Salisbury, United Kingdom.

Today we proudly announce the agreement of licensing terms for a novel One Step PCR technology employing reverse complement probes from the Salisbury NHS Foundation Trust, of Salisbury, United Kingdom.

Reverse Complement PCR (RC-PCR) technology permits the combined generation and flexible tagging of amplicon constructs from a target sequence or sequences in a single, closed tube amplification and indexing reaction.

NimaGen will utilize the technology to develop and market new kíts and panels for Next Generation Sequencing (NGS), bringing new tools to researchers working in this rapidly developing field.
These kits will augment NimaGen's existing strong portfolio in the capillary sequencing and Next Generation Sequencing market.

Under the terms of the agreement, NimaGen is granted a worldwide license for research applications including the development and sale of products for sample tracking & authentication within laboratories, high throughput screening and diagnostic research. NimaGen B.V. expect the first products to be available to customers in early 2019.

Download brochure EasySeq NGS RC-PCR

Point of contact Salisbury NHS Trust: Daniel Ward; email: danielward@nhs.net
Point of contact NimaGen B.V: Joop Theelen; email: j.theelen@nimagen.com

« back
This website uses cookies. Why? Click HERE for more information. [ CLOSE ]